MENU
NTLA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Intellia Therapeutics (NTLA) Ownership - Who owns Intellia Therapeutics?
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
526
Web
https://www.intelliatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.21B
P/E Ratio
N/A
Total Cash
503.75M
Projected Growth
N/A
Total Debt
119.25M
Revenue
45.57M
Risk (Beta)
2.22
Dividend Yield
N/A
Total Cash/Share
4.86
Total Debt/Equity
N/A
Revenue/Share
0.45 USD as % of share price
Fundamentals
NTLA
Capitalization
1.21B
P/E Ratio
N/A
Risk (Beta)
2.22
Dividend Yield
N/A
Total Cash
504M
Total Cash/Share
4.86
Total Debt
119M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.45%
Revenue
45.6M
ROE
N/A
Book Value
780M
P/B Ratio
1.64
Cash Flow
N/A
Earnings
-5.23
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10K
Current Ratio
4.90
Current Revenue Per Employee
11633.78
Dividends Per Share - Security
N/A
EBITDA
-530.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-46.84
Shares Held By Institutions
2.65B
Shares Outstanding - Current
104M
Total Liabilities
206M
Total Volume MTD
N/A
Value
1
Gain YTD
-0.172
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of proprietary, potentially curative therapeutics
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
40 Erie Street
Phone
+1 857 285-6200
Employees
526
Web
https://www.intelliatx.com